Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

Accueil
Investir
Actions
Etats-Unis
NYSE
Fresenius Medical Care AG (FMS)
Fresenius Medical Care AG (FMS) Actualités

Fresenius Medical Care AG (FMS)

Mis à jour : 20:40:49

Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis PR...

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million PR...

Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026 PR Newswire BAD...

Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with...

Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney...

Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer PR Newswire BAD HOMBURG, Germany...

Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of...

Aucune Discussion Trouvée

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.

Hot Features

Fresenius Medical Care AG (FMS)

Fresenius Medical Care AG (FMS) Actualités

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Fresenius Medical Care AG (FMS)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Fresenius Medical Care AG (FMS) Actualités

Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

Form SD - Specialized disclosure report

Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months

Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care

Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités